BioNTech SE BNTX:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 9:24 AM EDT
341.00quote price arrow up+1.74 (+0.51%)
Volume
29,924
Close
339.26quote price arrow down-2.09 (-0.61%)
Volume
1,423,075
52 week range
58.81 - 464.00
Loading...
  • Open342.80
  • Day High344.57
  • Day Low336.69
  • Prev Close339.26
  • 52 Week High464.00
  • 52 Week High Date08/10/21
  • 52 Week Low58.81
  • 52 Week Low Date09/24/20

Key Stats

  • Market Cap82.277B
  • Shares Out242.52M
  • 10 Day Average Volume3.51M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change316.17

KEY STATS

  • Open342.80
  • Day High344.57
  • Day Low336.69
  • Prev Close339.26
  • 52 Week High464.00
  • 52 Week High Date08/10/21
  • 52 Week Low58.81
  • 52 Week Low Date09/24/20
  • Market Cap82.277B
  • Shares Out242.52M
  • 10 Day Average Volume3.51M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change316.17

RATIOS/PROFITABILITY

  • EPS (TTM)19.38
  • P/E (TTM)17.51
  • Fwd P/E (NTM)7.94
  • EBITDA (MRQ)6.976B
  • ROE (MRQ)133.85%
  • Revenue (MRQ)9.08B
  • Gross Margin (MRQ)85.01%
  • Net Margin (MRQ)52.41%
  • Debt To Equity (MRQ)21.87%

EVENTS

  • Earnings Date11/09/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Related Video

VIDEO8:2908:29
Dr. Fauci on boosters, breakthrough cases and CDC data

Profile

MORE
BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. It develops a broad product pipeline using different scientific approaches and technology platforms, including individualized mRNA-based product candidates, chimeric antigen receptor T-cells, checkpoint immunomodulators, targeted cancer antibodies and small molecules. In addition, the Company...
Address
An der Goldgrube 12
Mainz
55131
Germany

Top Peers

SYMBOLLASTCHG%CHG
ILMN
Illumina Inc
434.59-0.17-0.04%
REGN
Regeneron Pharmaceuticals Inc
647.06+0.11+0.02%
BIIB
Biogen Inc
289.32-6.22-2.10%
MRNA
Moderna Inc
440.72+6.68+1.54%
GRFS
Grifols SA
15.29-0.31-1.99%